SinTilimab After Radiation (STAR Study)

Clinical trial NCT04167657 · COMPLETED

Trial details

NCT number: NCT04167657
Sponsor: Peking Union Medical College Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung

Start date: 2019-04-15
Primary completion: 2023-11-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.